KALA
KALA BIO, Inc. Common Stock
stockNASDAQ
At CloseNov 13, 2026 3:50:22 PM EST
0.14USD-15.404%(-0.03)908,247
Pre-marketNov 13, 2026 9:27:30 AM EST
0.1496USD-7.081%(-0.0114)
After-hoursNov 13, 2026 4:43:30 PM EST
0.1425USD+4.626%(+0.0063)
Loading…
Loading…
2.68M
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Mark Iwicki
HQ
Arlington, MA, USA
Previous Close
$0.16
Beta
2.68
52-Week High
$95.50 2025-12-01
52-Week Low
$0.11 2026-10-14
SMA 50
$0.34
SMA 200
$5.45
Avg. Vol 10D
192,009
Avg. Vol 30D
383,570
Avg. Vol 90D
1.12M
Relative Vol
1.78
19.34M
18.59M
96.11%
382,804
2.06%
1.81
44%/56%
55.30%
44.18%
12.9700%
200,000
516
91,362
364,612
Nov 18, 2026 (4d)
May 11, 2026 · 1-for-50 (reverse)
-10.1M
-1.31
-345.32
Nov 12, 2026
KALA BIO announces 1-for-30 reverse stock split · 
Seeking Alpha
Kala Bio announces 1-for-30 reverse stock split effective Friday · 
Investing.com
KALA BIO Announces Reverse Stock Split · 
Newsfile
Nov 9, 2026
Kala Bio reports 90% reduction in quarterly net loss · Investing.com
KALA BIO reports Q3 results · Seeking Alpha
KALA Profile
kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.
KALA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.16 | 2026-11-06 | -10.97% | 6.042 |
| 1M | 0.26 | 2026-10-13 | -46.62% | 3.656 |
| 3M | 0.92 | 2026-08-13 | -84.98% | 3.659 |
| 6M | 3.06 | 2026-05-13 | -95.46% | 2.783 |
| 1Y | 32.90 | 2025-11-13 | -99.58% | 2.680 |
| 2Y | 347.50 | 2024-11-13 | -99.96% | — |
| 5Y | 5,169.83 | 2021-11-12 | -100.00% | 1.138 |
KALA Stock Summary
KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $0.14, and today's volume is 682,358. KALA is down 13.789% today. The 30 day average volume is 383,570. KALA market cap is $2.68M with 19.34M shares outstanding.